Lupus education for physicians and patients in a resource-limited setting

  • Sandra V. NavarraEmail author
  • Leonid D. Zamora
  • Ma. Theresa M. Collante
Perspectives in Rheumatology
Part of the following topical collections:
  1. Empowering Medical Education to Transform: Learnings from an international perspective


Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of manifestations and potential to affect several organ systems. Complications arise from both disease and medications especially glucocorticoids, significantly contributing to overall morbidity and mortality. SLE predominantly affects patients during their prime productive years resulting in substantial economic burden on the patient, caregivers, and society due to direct, indirect, and intangible costs. This illness burden is compounded in developing countries with limited resources due to various disparities in healthcare delivery. Physician education and practical referral and endorsement guidelines adapted to the local setting reinforce continuity and coordinated care. Likewise, patient education, self-help programs, and shared decision-making are essential best practice in the clinics. Both physician education and patient education improve overall outcomes in chronic diseases like SLE. As a developing country with very few rheumatologists and/or lupus specialists, efficient healthcare delivery for most Filipino lupus patients remains elusive. We describe our experience in confronting these challenges through development of strategies which focus on physician and patient education.

Key Points

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a highly variable course, requiring specialized, individualized, and coordinated care by a healthcare team.

• Health disparities and limited resources significantly contribute to illness burden on the patient, family, and society.

• Physician education on SLE must commence at undergraduate medical school, be integrated in Internal Medicine and Pediatrics, and reinforced through specialized training in Rheumatology and related specialties.

• Patient education and empowerment are integral to improving healthcare outcomes especially in a resource-limited setting.


Education Lupus Patient  Physician Resource-limited SLE 



The authors thank Lupus Inspired Advocacy (LUISA) of Rheumatology Educational Trust Foundation, Inc. (RETFI).

Compliance with ethical standards




  1. 1.
    Navarra SV, Ishimori ML, Uy EA, Hamijoyo L, Sama J, James JA, Holers VM, Weisman MH (2011) Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives. Lupus. 20:537–543CrossRefGoogle Scholar
  2. 2.
    Vista ES, Weisman MH, Ishimori ML, Hamijoyo L, Navarra SV et al (2017) Strong viral associations with SLE among Filipinos. Lupus Sci Med 4(1):e000214CrossRefGoogle Scholar
  3. 3.
    Santos VD, Navarra SV (2017) Familiality and concordance of presenting manifestations among Filipino patients from lupus multiplex families (Abstract). Lupus Sci Med.
  4. 4.
    Lim KK, Chan M, Navarra SV, Haq SA, Lau CS (2016) Development and implementation of models of care for musculoskeletal conditions in middle-income and low-income Asian countries. Best Pract Res Clin Rheumatol 30(201):398e419Google Scholar
  5. 5.
    International Monetary Fund World Economic Outlook (2018). Accessed 18 April 2019
  6. 6.
    Deal CL, Hooker R, Harrington T, Birnbaum N, Hogan P, Bouchery E, Klein-Gitelman M, Barr W (2007) The United States rheumatology workforce: supply and demand, 2005–2025. Arthritis Rheum 56:722–729CrossRefGoogle Scholar
  7. 7.
    Velasco MG, Edar MFJ, Navarra SV (2017) Highest frequency of clinic visits and hospitalizations in SLE compared to other rheumatic diseases: 8-year census of a tertiary rheumatology center (Abstract). Lupus Sci Med.
  8. 8.
    Edar MFJ, Zamora L, Navarra SV (2017) Disease activity patterns among Filipino patients with systemic lupus erythematosus: a 3-year observational study (Abstract). Lupus Sci Med.
  9. 9.
    Pelo RJB, Santos VD, Bernal CB, Navarra SV (2017) Reasons for hospitalization among Filipino patients with SLE (Abstract). Lupus Sci Med.
  10. 10.
    Paras BM, Venegas ET, Navarra SV Predictors of end-stage renal disease in Filipinos with lupus nephritis: a case control study. (Abstract). Lupus Sci Med.
  11. 11.
    Kabadi S, Yeaw J, Bacani AK, Tafesse E, Bos K, Karkare S, DeKoven M, Vina ER (2018) Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus. Lupus 27(11):1799–1809CrossRefGoogle Scholar
  12. 12.
    Yelin E, Yazdany J, Trupin L (2017) Relationship between process of care and a subsequent increase in damage in systemic lupus erythematosus. Arthritis Care Res 69(6):927–932CrossRefGoogle Scholar
  13. 13.
    Department of Health (2017). Philippine Health Agenda 2016 – 2022, Manila, Philippines: Department of Health. Accessed 18 April 2019
  14. 14.
    Veñegas E, Geslani K, Navarra S (2018) Hospitalizations, renal activity and damage incur the highest medical costs among Filipino patients with systemic lupus erythematosus. Philippine J Intern Med 56(2):77–81Google Scholar
  15. 15.
    Yelin E, Trupin L, Bunde J, Yazdany J (2019) Poverty, neighborhoods, persistent stress, and systemic lupus erythematosus outcomes: a qualitative study of the patients’ perspective. Arthritis Care Res 71(3):398–405Google Scholar
  16. 16.
    Navarra SV, Tanangunan RD, Esquibel IC (2019) Lupus among Filipinos: unmet needs. Philippine J Intern Med 57(1):1–5Google Scholar
  17. 17.
    Tikly M, Navarra SV (2008) Lupus in the developing world - is it any different? Best Pract Res Clin Rheumatol 22(4):643–655CrossRefGoogle Scholar
  18. 18.
    Patow C, Bryan D, Johnson G, Canaan E, Oyewo A, Panda M, Walsh E, Zaidan J (2016) Who’s in our neighborhood? Healthcare disparities experiential education for residents. Ochsner J 16:41–44PubMedPubMedCentralGoogle Scholar
  19. 19.
    Katz SJ, Yacyshyn EA (2009) Attracting internal medicine trainees to rheumatology: where and when programs should focus efforts. J Rheumatol 36(12):2802–2805CrossRefGoogle Scholar
  20. 20.
    Franks P, Fiscella K (2008) Reducing disparities downstream: prospects and challenges. J Gen Intern Med 23(5):672–677CrossRefGoogle Scholar
  21. 21.
    Gladman D, Urowitz M, Esdaile J, Pack M et al (1999) Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum 42(9):1785–1796CrossRefGoogle Scholar
  22. 22.
    Arora S, Nika A, Trupin L, Abraham H, Block J, Sequeira W, Yazdany J, Jolly M (2018) Does systemic lupus erythematosus care provided in a lupus clinic result in higher quality of care than that provided in a general rheumatology clinic? Arthritis Care Res 70(12):1771–1777CrossRefGoogle Scholar
  23. 23.
    Son MBF, Sergeyenko Y, Guan H, Costenbader KH (2016) Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort. Lupus 25(13):1431–1439CrossRefGoogle Scholar
  24. 24.
    Sadun RE, Schanberg LE (2018) Transition and transfer of the patient with paediatric-onset lupus: a practical approach for paediatric and adult rheumatology practices. Lupus Sci Med 5(1):e000282CrossRefGoogle Scholar
  25. 25.
    Nafradi L, Nakamoto K, Schulz PJ (2017) Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PLoS ONE 12(10):e0186458CrossRefGoogle Scholar
  26. 26.
    Hickman RJ (2018) Why & how to pursue shared decision making with your patients. The Rheumatologist. Accessed 18 April 2019
  27. 27.
    Grad R, Légaré F, Bell NR, Dickinson JA, Singh H, Moore AE, Kasperavicius D, Kretschmer KL (2017) Shared decision making in preventive health care: what it is; what it is not. Can Fam Physician 63:682–684PubMedPubMedCentralGoogle Scholar
  28. 28.
    Mahieu M, Yount S, Ramsey-Goldman R (2016) Patient-reported outcomes in systemic lupus erythematosus. Rheum Dis Clin N Am 42(2):253–263CrossRefGoogle Scholar
  29. 29.
    Izadi Z, Gandrup J, Katz PP, Yazdany J (2018) Patient-reported outcome measures for use in clinical trials of SLE: a review. Lupus Sci Med 5:e000279CrossRefGoogle Scholar
  30. 30.
    Wilkerson L, Fung CC, May W, Elliott D (2010) Assessing patient-centered care: one approach to health disparities education. J Gen Intern Med 25(Suppl 2):86–90CrossRefGoogle Scholar
  31. 31.
    Kandane-Rathnayake R, Golder V, Louthrenoo W, Navarra SV, Zamora L et al (2019) Development of the Asia Pacific Lupus Collaboration cohort. Int J Rheum Dis 22(3):425–433CrossRefGoogle Scholar
  32. 32.
    Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF, Asia-Pacific Lupus Collaboration (2016) Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis 75:1615–1621CrossRefGoogle Scholar
  33. 33.
    Golder V, Kandane-Rathnayake R, Hoi A, Zamora L, Navarra SV et al (2017) Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study. Arthritis Res Ther 19:62CrossRefGoogle Scholar
  34. 34.
    Golder V, Kandane-Rathnayake R, Hoi A, Zamora L, Navarra SV et al (2016) Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort. Arthritis Res Ther 18:260CrossRefGoogle Scholar
  35. 35.
    Haupt M, Millen S, Jänner M, Falagan D, Fischer-Betz R, Schneider M (2005) Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 64(11):1618–1623CrossRefGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2019

Authors and Affiliations

  1. 1.Section of RheumatologyUniversity of Santo TomasManilaPhilippines
  2. 2.Section of Pediatric RheumatologyUniversity of Santo TomasManilaPhilippines

Personalised recommendations